Score Overview
See the full market ranking โ
Purple Biotech fundamental performance
Between 2020 and 2025, revenue declined from $ 1M to $ 0.00 and net income went from -$ 27M to -$ 26M. Revenue increased in 1 of those 5 years; net income in 2.
Purple Biotech currently holds a 5-year HDB Score of 3.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.48 | โ |
1 Year2025-08-12 | $ 22.50 | -93.42% |
5 Years2021-08-12 | $ 944.00 | -99.84% |
10 Years2016-08-12 | $ 6.12K | -99.98% |
All Time2015-11-20 | $ 6.38K | -99.98% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2015-11-20 |
|---|---|---|---|---|---|
| Price | $ 1.48 | $ 22.50 | $ 944.00 | $ 6.12K | $ 6.38K |
| Return | โ | -93.42% | -99.84% | -99.98% | -99.98% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 24M | |
| 2025 | $ 0.00 | -$ 26M | $ 9M |
| 2024 | $ 0.00 | -$ 7M | $ 8M |
| 2023 | $ 195.8K | -$ 19.88K | $ 15M |
| 2022 | -$ 910K | -$ 21M | $ 32M |
| 2021 | -$ 320K | -$ 18M | $ 47M |
| 2020 | $ 1M | -$ 27M | $ 57M |
| 2019 | $ 1M | -$ 5M | $ 6M |
| 2018 | $ 1M | -$ 5M | $ 5M |
| 2017 | $ 100K | -$ 12M | $ 3M |
| 2016 | -$ 12M | $ 14M | |
| IPO2015 | -$ 4M | $ 10M |
Explore beyond PPBT
You're looking at Purple Biotech. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
